These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20542521)
1. Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. Eser D; Uhr M; Leicht G; Asmus M; Länger A; Schüle C; Baghai TC; Mulert C; Rupprecht R J Psychiatr Res; 2011 Jan; 45(1):60-3. PubMed ID: 20542521 [TBL] [Abstract][Full Text] [Related]
2. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers. Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107 [TBL] [Abstract][Full Text] [Related]
3. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI. Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136 [TBL] [Abstract][Full Text] [Related]
4. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects. Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429 [TBL] [Abstract][Full Text] [Related]
5. Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Fujimoto M; Uchida S; Watanuki T; Wakabayashi Y; Otsuki K; Matsubara T; Suetsugi M; Funato H; Watanabe Y Neurosci Lett; 2008 Jun; 438(2):196-9. PubMed ID: 18455873 [TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin and panic disorder: past and future clinical research strategies. Bradwejn J; Koszycki D Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976 [TBL] [Abstract][Full Text] [Related]
7. Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Politi P; Minoretti P; Falcone C; Martinelli V; Emanuele E Neurosci Lett; 2006 Mar; 396(2):163-6. PubMed ID: 16352396 [TBL] [Abstract][Full Text] [Related]
8. Dose ranging study of the effects of cholecystokinin in healthy volunteers. Bradwejn J; Koszycki D; Bourin M J Psychiatry Neurosci; 1991 Jul; 16(2):91-5. PubMed ID: 1911739 [TBL] [Abstract][Full Text] [Related]
9. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks. Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215 [TBL] [Abstract][Full Text] [Related]
10. Unease on the role of glyoxalase 1 in high-anxiety-related behaviour. Thornalley PJ Trends Mol Med; 2006 May; 12(5):195-9. PubMed ID: 16616641 [TBL] [Abstract][Full Text] [Related]
11. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. Maron E; Tõru I; Vasar V; Shlik J J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907 [TBL] [Abstract][Full Text] [Related]
12. The acute antipanic and anxiolytic activity of aerobic exercise in patients with panic disorder and healthy control subjects. Ströhle A; Graetz B; Scheel M; Wittmann A; Feller C; Heinz A; Dimeo F J Psychiatr Res; 2009 Aug; 43(12):1013-7. PubMed ID: 19289240 [TBL] [Abstract][Full Text] [Related]
13. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Ströhle A; Holsboer F; Rupprecht R Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152 [TBL] [Abstract][Full Text] [Related]
14. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers. Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011 [TBL] [Abstract][Full Text] [Related]
15. Effects of repetitive transcranial magnetic stimulation (rTMS) on panic attacks induced by cholecystokinin-tetrapeptide (CCK-4). Zwanzger P; Eser D; Völkel N; Baghai TC; Möller HJ; Rupprecht R; Padberg F Int J Neuropsychopharmacol; 2007 Apr; 10(2):285-9. PubMed ID: 16817979 [TBL] [Abstract][Full Text] [Related]
16. Effect of oral ondansetron on total cholecystokinin plasma levels following CCK-4 panic challenge procedure in healthy men. Dépôt M; Merani S; Bradwejn J; Mukherjee J; Caillé J; Gutkowska J; Caillé G J Psychiatry Neurosci; 1998 Nov; 23(5):298-304. PubMed ID: 9846035 [TBL] [Abstract][Full Text] [Related]